Catheter Precision Wins Two Patents for VIVO and Cardionomix
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
FORT MILL, S.C., March 6, 2026 Catheter Precision, Inc., a U.S.-based medical technology company specializing in cardiac electrophysiology innovations,...
SAN DIEGO, Feb. 2026 — Field Medical presented new clinical findings from its PULSE clinical study evaluating pulsed field...
